Skip to main content

7 Result(s)

within Nina G. **e Remove this filter Biomedicine Remove this filter Neurosciences Remove this filter

and

  1. Article

    Open Access

    A pilot study to evaluate the effect of CT1812 treatment on synaptic density and other biomarkers in Alzheimer’s disease

    Effective, disease-modifying therapeutics for the treatment of Alzheimer’s disease (AD) remain a large unmet need. Extensive evidence suggests that amyloid beta (Aβ) is central to AD pathophysiology, and Aβ ol...

    Christopher H. van Dyck, Adam P. Mecca, Ryan S. O’Dell… in Alzheimer's Research & Therapy (2024)

    Download PDF (1725 KB) View Article

  2. Article

    Open Access

    Transient overexpression of alpha-Synuclein in OLN-93 oligodendroglial cells is not cytotoxic and not affected by HSP70

    Petra Scholz, Nina G Bauer, Gerald Thiel, Christiane Richter-Landsberg in BMC Neuroscience (2007)

    Download PDF (81 KB) View Article

  3. No Access

    Article

    Preferences among four combination nicotine treatments

    Acute nicotine replacement treatments (NRTs) are disliked or misused, leading to insufficient nicotine intake and poor outcome. Patches provide steady nicotine but are slow and passive. Combining systems may i...

    Nina G. Schneider, Margaret A. Koury, Chris Cortner… in Psychopharmacology (2006)

  4. No Access

    Article

    The dynamic instability of microtubules is required for aggresome formation in oligodendroglial cells after proteolytic stress

    Ubiquitinated tau-positive inclusion bodies in oligodendrocytes are consistent features in a variety of neurodegenerative disorders, and their formation points to an underlying incapacity of the protein qualit...

    Nina G. Bauer, Christiane Richter-Landsberg in Journal of Molecular Neuroscience (2006)

  5. No Access

    Article

    Comparison of three nicotine treatments: initial reactions and preferences with guided use

    Misuse or dislike of nicotine replacement treatments (NRTs) undermines their effectiveness. Brief testing among NRTs could allow tailoring by preference to improve outcome.

    Nina G. Schneider, Scott Terrace, Margaret A. Koury, Shilpan Patel… in Psychopharmacology (2005)

  6. No Access

    Article

    Time course of smoking withdrawal symptoms as a function of nicotine replacement

    Subjects (N=32) provided morning, afternoon, and evening data for week-1 withdrawal from smoking. Withdrawal symptoms were measured using Schneider's Smoker Complaint Scale. Twenty subjects received nicotine gum ...

    Nina G. Schneider, Murray E. Jarvik in Psychopharmacology (1983)

  7. No Access

    Article

    Can cigarette size and nicotine content influence smoking and puffing rates?

    The stimuli controlling the rate at which people smoke cigarettes have not been clearly defined. On the hypothesis that smoking is basically nicotine-seeking behavior. nicotine available to the subject was exp...

    Murray E. Jarvik, Paulene Popek, Nina G. Schneider, Vivian Baer-Weiss… in Psychopharmacology (1978)